Related Experiment Video
Updated: May 11, 2026

09:32
Electrospun Nanofiber Scaffolds with Gradations in Fiber Organization
Published on: April 19, 2015
Dual Acidic pH-Responsive Post-Crosslinked E-Spun Nanofibrous Scaffolds Exhibiting Enhanced Disassembly and Release
Sofia Nieves Casillas-Popova1, Arianna Cirillo1, Cameron D Skinner1
1Department of Chemistry and Biochemistry, Concordia University, Montreal, Quebec, Canada.
Advanced Healthcare Materials
|May 10, 2026
Summary
This study introduces dual pH-responsive nanofibrous mats for localized cancer treatment. These mats degrade in acidic conditions, enabling controlled release of anticancer drugs for improved chemotherapy.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Electrospun nanofibrous mats offer potential for localized cancer treatment and tissue regeneration.
- Conventional scaffolds face challenges with delayed and uncontrolled drug release due to weak crosslinking.
Purpose of the Study:
- To develop dual acidic pH-responsive degradable electrospun nanofibrous mats for enhanced localized cancer chemotherapy.
- To address limitations of inefficient crosslinking and drug release in current nanofibrous scaffolds.
Main Methods:
- Synthesis of a phenyl diboronic acid crosslinker with an acid-cleavable Schiff base linkage.
- Fabrication of dual smart mats crosslinked with acid-labile imine and boronic ester linkages.
- Evaluation of degradation profiles, drug release kinetics, antitumoral activity, and hemocompatibility.
Main Results:
- The dual smart mats exhibited rapid degradation in acidic environments via acid-catalyzed hydrolysis.
- Enhanced release of encapsulated anticancer drugs was observed upon degradation.
- Doxorubicin-loaded mats demonstrated significant antitumoral activity and hemocompatibility.
- Empty mats showed good biocompatibility.
Conclusions:
- Dual acidic pH-responsive degradable electrospun nanofibrous mats show great potential as implantable scaffolds for localized cancer drug delivery.
- The developed system offers a promising strategy for controlled and enhanced chemotherapy.
- This approach overcomes limitations of conventional drug delivery systems for cancer treatment.

